- Report
- January 2023
- 221 Pages
Global
From €5581EUR$5,730USD£4,771GBP
- Book
- January 2021
- 400 Pages
The Cardiac Regeneration market is a subset of the biotechnology industry focused on the development of treatments and therapies to regenerate damaged heart tissue. This includes the use of stem cells, gene therapy, and other regenerative medicine approaches to repair and replace damaged heart tissue. The goal of cardiac regeneration is to restore the heart's ability to pump blood and improve the quality of life for those suffering from heart disease.
The Cardiac Regeneration market is driven by the increasing prevalence of heart disease, as well as the need for more effective treatments. Research and development in this field is ongoing, with a focus on improving the safety and efficacy of treatments.
Companies in the Cardiac Regeneration market include Athersys, Inc., Capricor Therapeutics, Inc., and Cytori Therapeutics, Inc. These companies are focused on developing treatments and therapies to improve the quality of life for those suffering from heart disease. Show Less Read more